metastatic PDAC

SAN DIEGO, May 28, 2026 Phanes Therapeutics announced updated positive Phase 2 clinical trial results for spevatamig (PT886) in...

San Diego, California, USA – April 22, 2026 In a significant development in oncology drug innovation, Phanes Therapeutics has...